When will Semaglutide Tablet be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Semaglutide Tablet changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Semaglutide Tablet

Brand names: Rybelsus

Category: Endocrinology/Metabolism

Not specified 3

FDA status: To Be Discontinued · Last FDA update: Jun 4, 2026 · First posted: Jun 4, 2026 · 1 manufacturers, 3 listed presentations

As of Jun 4, 2026, the FDA lists Semaglutide Tablet as being discontinued. Of 3 manufacturer presentations, 3 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Semaglutide Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Rybelsus, Tablet, 3 mg (NDC 0169-4303-30) NDC 0169-4303-30	Novo Nordisk, Inc.	Not specified	Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
Rybelsus, Tablet, 7 mg (NDC 0169-4307-30) NDC 0169-4307-30	Novo Nordisk, Inc.	Not specified	Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
Rybelsus, Tablet, 14 mg (NDC 0169-4314-30) NDC 0169-4314-30	Novo Nordisk, Inc.	Not specified	Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.

Related medications in shortage

Other Endocrinology/Metabolism medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Semaglutide Tablet (FDA data as of Jun 4, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Semaglutide Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Semaglutide Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/semaglutide-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).